Correlation between Selected Clinical Symptoms and Severity of Aggression, Impulsiveness and Their Selected Behavioral Manifestations in Patients with Polycystic Ovary Syndrome Phenotype A.
BMI
PCOS
alcohol consumption patterns
eating habits
psychoneuroendocrinology
risky sexual behavior
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
09 May 2023
09 May 2023
Historique:
received:
16
02
2023
revised:
24
03
2023
accepted:
08
05
2023
medline:
26
5
2023
pubmed:
26
5
2023
entrez:
26
5
2023
Statut:
epublish
Résumé
Previous studies on aggressiveness and impulsiveness in women with polycystic ovary syndrome (PCOS) are ambiguous. Furthermore, no biochemical or clinical factors related to these variables have been definitively confirmed. The aim of the study was to clarify whether, in women with phenotype A of PCOS, variables such as body mass index and clinical and biochemical hyperandrogenism have an impact on either the intensity of impulsivity or aggression or on other selected behavioral manifestations of these variables. The study included 95 patients diagnosed with PCOS phenotype A. The criterion for recruitment into the study group and the control group was body mass index. The study was conducted with the use of a closed-format questionnaire and calibrated clinical scales. Higher body mass index (BMI) values in women with PCOS phenotype A are associated with poor eating habits. The severity of impulsivity and aggression syndrome, as well as the tendency to engage in risky sexual behavior and patterns of alcohol consumption among patients diagnosed with PCOS phenotype A, are not dependent on BMI. The severity of impulsiveness and the syndrome of aggression in women with phenotype A PCOS are not associated with clinical symptoms of hyperandrogenism or with androgen levels.
Identifiants
pubmed: 37233687
pii: metabo13050646
doi: 10.3390/metabo13050646
pmc: PMC10224027
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Endokrynol Pol. 2018;69(4):
pubmed: 30209800
BMC Endocr Disord. 2020 Jan 30;20(1):19
pubmed: 32000752
Gynecol Endocrinol. 2020 Feb;36(2):96-103
pubmed: 31559883
Psychoneuroendocrinology. 2018 Feb;88:105-114
pubmed: 29197795
Fertil Steril. 2018 May;109(5):888-899
pubmed: 29778388
Arch Sex Behav. 2019 Feb;48(2):481-494
pubmed: 30671876
J Hum Reprod Sci. 2018 Jan-Mar;11(1):10-18
pubmed: 29681710
Psychiatr Pol. 2013 Jan-Feb;47(1):103-15
pubmed: 23888748
Psychoneuroendocrinology. 2013 Mar;38(3):416-24
pubmed: 22854014
Gynecol Endocrinol. 2018 Jul;34(7):597-600
pubmed: 29336189
J Endocrinol Invest. 2021 Mar;44(3):505-513
pubmed: 32557272
Nutrients. 2022 Oct 28;14(21):
pubmed: 36364814
Ginekol Pol. 2020;91(10):595-599
pubmed: 33184827
J Clin Med. 2019 Oct 14;8(10):
pubmed: 31615157
Int J Environ Res Public Health. 2021 Nov 27;18(23):
pubmed: 34886216
Fertil Steril. 2017 Mar;107(3):796-802
pubmed: 28104244
Psychiatr Hung. 2016;31(2):136-45
pubmed: 27244869
Neuropsychiatr Dis Treat. 2019 May 16;15:1273-1285
pubmed: 31190833
Int J Psychiatry Med. 2015;50(3):317-25
pubmed: 26449924
Biol Psychol. 2021 Apr;161:108073
pubmed: 33727106
Clin Endocrinol (Oxf). 2020 Apr;92(4):338-349
pubmed: 31917860
J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):203-11
pubmed: 25001653
J Affect Disord. 2019 Jun 15;253:385-393
pubmed: 31082731
Curr Pharm Des. 2018;24(9):999-1006
pubmed: 29205115
Nutrients. 2021 Jan 22;13(2):
pubmed: 33499268
Reprod Sci. 2021 Nov;28(11):3181-3192
pubmed: 34076876
Saudi J Biol Sci. 2020 Dec;27(12):3342-3347
pubmed: 33304140
Am J Drug Alcohol Abuse. 2018;44(6):578-586
pubmed: 29723083
Alcohol Clin Exp Res. 2008 Sep;32(9):1681-7
pubmed: 18631324
J Clin Endocrinol Metab. 2015 Mar;100(3):911-9
pubmed: 25532045
Physiol Behav. 2001 May;73(1-2):217-21
pubmed: 11399314
Iran J Psychiatry. 2016 Jan;11(1):43-50
pubmed: 27252768
Arch Gynecol Obstet. 2015 Feb;291(2):451-5
pubmed: 25138126
Arch Sex Behav. 2009 Dec;38(6):936-48
pubmed: 18563548
Indian J Psychol Med. 2015 Jul-Sep;37(3):317-21
pubmed: 26664080
J Subst Abuse Treat. 2018 Aug;91:49-56
pubmed: 29910014
Fertil Steril. 2019 Aug;112(2):353-361
pubmed: 31056307
Health Qual Life Outcomes. 2020 Jul 16;18(1):232
pubmed: 32677953
J Psychosom Obstet Gynaecol. 2011 Jun;32(2):104-11
pubmed: 21473679
Am J Med Genet B Neuropsychiatr Genet. 2016 Jul;171(5):650-75
pubmed: 26494515
Reprod Biomed Online. 2019 Jun;38(6):979-989
pubmed: 30926178
Reprod Sci. 2020 Jan;27(1):432-442
pubmed: 32046411
J Sex Med. 2012 Jan;9(1):224-30
pubmed: 22082203
Arch Womens Ment Health. 2021 Feb;24(1):11-27
pubmed: 32514730
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:5-10
pubmed: 27770705
J Psychosom Obstet Gynaecol. 2018 Jun;39(2):128-137
pubmed: 28385114
Psychoneuroendocrinology. 2008 Sep;33(8):1132-8
pubmed: 18672334